chr13-102846111-C-A

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Supporting

The NM_000123.4(ERCC5):c.-156C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000157 (AC=99) in the gnomAD database across 631,502 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000351. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

ERCC5
NM_000123.4 5_prime_UTR

Scores

3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0290

Publications

0 publications found
Variant links:
Genes affected
ERCC5 (HGNC:3437): (ERCC excision repair 5, endonuclease) This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011]
ERCC5 Gene-Disease associations (from GenCC):
  • xeroderma pigmentosum group G
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia, G2P, ClinGen
  • cerebrooculofacioskeletal syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum-Cockayne syndrome complex
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
BIVM-ERCC5 (HGNC:43690): (BIVM-ERCC5 readthrough) This locus represents naturally occurring read-through transcription between the neighboring BIVM (basic, immunoglobulin-like variable motif containing) and ERCC5 (excision repair cross-complementing rodent repair deficiency, complementation group 5) genes on chromosome 13. The read-through transcript encodes a fusion protein that shares sequence identity with the products of each individual gene. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000123.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000035 — very rare (O3 supporting [+1])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000123.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ERCC5 NM_000123.4
MANE Select
HGVSc / HGVSpc.-156C>A
Exon rankExon 1 of 15
5_prime_UTR
Prot: NP_000114.3
BIVM-ERCC5 NM_001204425.2
HGVSc / HGVSpc.1451-6007C>A
Exon rankIntron 9 of 22
intron
Prot: NP_001191354.2UniProt: A0A1W2PPV1R4GMW8Q59FZ7

Ensembl Transcripts

ERCC5 ENST00000652225.2
MANE Select
HGVSc / HGVSpc.-156C>A
Exon rankExon 1 of 15
5_prime_UTR
Prot: ENSP00000498881.2UniProt: P28715-1
BIVM-ERCC5 ENST00000639435.1
TSL:5
HGVSc / HGVSpc.1451-6007C>A
Exon rankIntron 11 of 24
intron
Prot: ENSP00000491742.1UniProt: A0A1W2PPV1
BIVM-ERCC5 ENST00000639132.1
TSL:5
HGVSc / HGVSpc.764-6007C>A
Exon rankIntron 10 of 23
intron
Prot: ENSP00000492684.1UniProt: A0A1W2PS85

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.000164
AC:25
Hom:0
AN:152220
Cov:33
GnomAD4 exome
AF: 0.000154
AC:74
Hom:0
AN:479282
Cov:5
GnomAD4 genome
AF: 0.000164
AC:25
Hom:0
AN:152220
Cov:33
TOPMed (Bravo)
AF: 0.0000113
AC:3
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:17210
Showing 5 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.000222 1567698 0.000283 31109426
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Xeroderma pigmentosum, group G (1)

Computational Scores

AlphaGenome AVI
Benign1.9
BayesDel_noAF
Benign-0.73
CADD
Benign5.1
DANN
Benign0.79
GPN-Star LLR
N/A0.75
GPN-Star score
N/A-0.75
PhyloP100
Benign-0.029
PromoterAI
N/A0.015Neutral
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.